title: [Utility of the copper/zinc ratio in patients with lymphoma or acute or chronic leukemias].
abstract: OBJECTIVE
  To determine the diagnostic value of serum levels of copper, zinc and the Cu/Zn ratio in patients with hematological malignancies compared to gender- and age-matched control subjects.
  
  
  METHODS
  A total of 44 patients with recently diagnosed and non-treated hematological malignancies were included: 17 lymphoma (11 non-Hodgkin), 15 acute leukemia (10 myeloblastic), and 12 with chronic leukemia (8 granulocytic); 95 healthy subjects were included. Copper and zinc serum levels were measured with a Perkin Elmer (model 2380) atomic absorption spectrophotometer.
  
  
  RESULTS
  Serum copper levels (microgram/dL) were significantly lower in healthy subjects (54.4 +/- 8.9, p < 0.05) compared to patients with lymphoma (93.7 +/- 37.5), acute leukemia (80.6 +/- 44.6) or chronic leukemia (95.7 +/- 28.9) while serum zinc levels (microgram/dL) were significantly higher in healthy control subjects (100.4 +/- 14, p < 0.05) compared to patients with lymphoma (77.2 +/- 22.6), acute leukemia (66 +/- 15.6), or chronic leukemia (74.8 +/- 14.7). The Cu/Zn ratio was significantly lower in healthy subjects (0.54 +/- 0.13, p < 0.05) than in patients with lymphoma (1.21 +/- 0.5), acute leukemia (1.22 +/- 0.7), or chronic leukemia (1.28 +/- 0.4). Twenty three patients died during a mean follow-up period of 13 months and their serum zinc levels were significantly lower (68 +/- 21) than in the living patients (76 +/- 15, p < 0.05).
  
  
  CONCLUSIONS
  Cu/Zn ratio is significantly higher in patients with lymphoma or acute and chronic leukemias compared to gender- and age-matched control subjects.
authors.affiliation: Departamentos de Hematología, Instituto Nacional de la Nutrición Salvador Zubirán, México.
authors.forename: R
authors.initials: R
authors.lastname: Rosas
authors.forename: J L
authors.initials: JL
authors.lastname: Poo
authors.forename: A
authors.initials: A
authors.lastname: Montemayor
authors.forename: F
authors.initials: F
authors.lastname: Isoard
authors.forename: A
authors.initials: A
authors.lastname: Majluf
authors.forename: J
authors.initials: J
authors.lastname: Labardini
mesh_terms: D000208:Acute Disease; D000328:Adult; D001772:Blood Cell Count; D001798:Blood Proteins / Q000032:analysis; D002908:Chronic Disease; D003300:Copper / Q000097:blood*; D005260:Female; D006801:Humans; D007938:Leukemia / Q000097:blood* / Q000401:mortality; D008228:Lymphoma, Non-Hodgkin / Q000097:blood* / Q000401:mortality; D008297:Male; D008800:Mexico / Q000453:epidemiology; D008875:Middle Aged; D011379:Prognosis; D011446:Prospective Studies; D015032:Zinc / Q000097:blood* / Q000172:deficiency
chemical_list: D001798:Blood Proteins; D003300:Copper; D015032:Zinc